Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin adjunctive therapy for primary generalized tonic-clonic seizures
2010-023263-18Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in generalized tonic-clonic seizure (GTCS) comparing Pregabalin adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Primary endpoint: log-transformed 28-day PGTC seizure rate. Started Apr 2013; status: completed.
02
Drugs
pregabalin
03
Conditions
generalized tonic-clonic seizure (GTCS)
Beyond the preview
Go deeper on 2010-023263-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023263-18.